NEW YORK (GenomeWeb News) - Invitrogen will use Genetix's ClonePixFL technology in its process-development services, the company said today.
 
The technology will be offered through Invitrogen's PD-Direct offering.
 
Invitrogen also said it will develop applications to integrate ClonePixFL with its Revolution technology.
 
The Genetix ClonePixFL automatically images and selects mammalian cell colonies based upon a set of parameters.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.